Thus, central nervous system tau deposits expedite neurogenic sarcopenia onset, highlighting a distinct gap between the fast‐paced muscle pathology and the more delayed cognitive decline in the PS19 AD model. This evidence concerns the gene MAPT and Alzheimer disease.